Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol., 18 May 2022
Sec. Gastrointestinal and Hepatic Pharmacology
This article is part of the Research Topic Natural Product Treatment of Gastrointestinal Diseases View all 11 articles

RETRACTED: Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990

Retracted
Bin Chen&#x;Bin Chen1Linguangjin Wu&#x;Linguangjin Wu1Xiaoxia Tang&#x;Xiaoxia Tang1Ting WangTing Wang1Shuyun WangShuyun Wang1Hongjie YuHongjie Yu1Guangsheng WanGuangsheng Wan1Manli XieManli Xie1Ruijuan Zhang
&#x;Ruijuan Zhang2*Haijuan Xiao
&#x;Haijuan Xiao3*Wanli Deng
&#x;Wanli Deng1*
  • 1Department of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
  • 2Department of Traditional Chinese Medicine, Putuo People’s Hospital, Tongji University, Shanghai, China
  • 3Department of Oncology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China
This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Chen B, Wu L, Tang X, Wang T, Wang S, Yu H, Wan G, Xie M, Zhang R, Xiao H and Deng W (2022) Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990. Front. Pharmacol. 13:874696. doi: 10.3389/fphar.2022.874696

Received: 12 February 2022; Accepted: 07 April 2022;
Published: 18 May 2022; Retracted: 06 July 2023.

Edited by:

Hailian Shi, Shanghai University of Traditional Chinese Medicine, China

Reviewed by:

Liqun Jia, China-Japan Friendship Hospital, China
Li Feng, National Cancer Center of China, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.